CSIMarket


Bioxcel Therapeutics Inc   (BTAI)
Other Ticker:  
 

Bioxcel Therapeutics Inc

BTAI's Fundamental analysis








Looking into Bioxcel Therapeutics Inc growth rates, revenue grew by 57.98 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 514

Major Pharmaceutical Preparations industry recorded deterioration of revenues by

Bioxcel Therapeutics Inc net loss deacreased by in IV. Quarter 2023 year on year, Bioxcel Therapeutics Inc net loss increased by -59.39 % in IV. Quarter 2023 year on year,

More on BTAI's Growth


Bioxcel Therapeutics Inc
realized net loss in trailing twelve months.

Bioxcel Therapeutics Inc realized cash outflow of $ -4.41per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
368.66
PE TTM    
Company's Price to Sales ratio is at 62.66.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.46.


More on BTAI's Valuation
 
 Total Debt (Millions $) 101
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 27,059
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 3.63
 Tangible Book Value (Per Share $) -1.94

Bioxcel Therapeutics Inc
realized net loss in trailing twelve months.

Bioxcel Therapeutics Inc realized cash outflow of $ -4.41per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
368.66
PE TTM    
Company's Price to Sales ratio is at 62.66.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.46.


More on BTAI's Valuation

  Market Capitalization (Millions $) 86
  Shares Outstanding (Millions) 29
  Employees 51
  Revenues (TTM) (Millions $) 1
  Net Income (TTM) (Millions $) -179
  Cash Flow (TTM) (Millions $) -129
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) 101
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 27,059
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 3.63
  Tangible Book Value (Per Share $) -1.94

  Market Capitalization (Millions $) 86
  Shares Outstanding (Millions) 29
  Employees 51
  Revenues (TTM) (Millions $) 1
  Net Income (TTM) (Millions $) -179
  Cash Flow (TTM) (Millions $) -129
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 2.65
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.01
  Inventory Turnover Ratio (TTM) 0.64





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com